LPTX icon

Leap Therapeutics
LPTX

Overview Fund Trends Analyst Outlook Journalist POV

15 hedge funds and large institutions have $3.71M invested in Leap Therapeutics in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

64% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 11

Holders
15
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$576K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$533K
2
+$18K
3
+$3.7K

Top Sellers

1
-$941K
2
-$72K
3
-$42K
4
VF
Virtu Financial
New York
-$28K
5
ARTA
A.R.T. Advisors
New York
-$23K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.1M
2
$753K
3
$740K
4
$533K
5
$184K
6
$168K
7
$90K
8
$56K
9
$36K
10
$25K
11
$18K
12
$7K
13
–
14
–
15
–
16
–
17
–
18
–
19
–
20
–